166 related articles for article (PubMed ID: 25466863)
1. BMI and breast cancer prognosis benefit: mammography screening reveals differences between normal weight and overweight women.
Crispo A; Grimaldi M; D'Aiuto M; Rinaldo M; Capasso I; Amore A; D'Aiuto G; Giudice A; Ciliberto G; Montella M
Breast; 2015 Feb; 24(1):86-9. PubMed ID: 25466863
[TBL] [Abstract][Full Text] [Related]
2. Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women.
Biglia N; Peano E; Sgandurra P; Moggio G; Pecchio S; Maggiorotto F; Sismondi P
Gynecol Endocrinol; 2013 Mar; 29(3):263-7. PubMed ID: 23174088
[TBL] [Abstract][Full Text] [Related]
3. Overweight, obesity, and breast cancer screening: results from the 2012 Swiss Health Survey.
Eichholzer M; Richard A; Rohrmann S; Schmid S; Güth U
Eur J Cancer Prev; 2016 Mar; 25(2):130-6. PubMed ID: 25793921
[TBL] [Abstract][Full Text] [Related]
4. Body mass index and prognosis of breast cancer: An analysis by menstruation status when breast cancer diagnosis.
Sun L; Zhu Y; Qian Q; Tang L
Medicine (Baltimore); 2018 Jun; 97(26):e11220. PubMed ID: 29952978
[TBL] [Abstract][Full Text] [Related]
5. Does obesity have an effect on outcomes in triple-negative breast cancer?
Mowad R; Chu QD; Li BD; Burton GV; Ampil FL; Kim RH
J Surg Res; 2013 Sep; 184(1):253-9. PubMed ID: 23768767
[TBL] [Abstract][Full Text] [Related]
6. The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women.
Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K
J BUON; 2013; 18(2):335-41. PubMed ID: 23818343
[TBL] [Abstract][Full Text] [Related]
7. 'Weighing in' on screening mammography.
Berz D; Sikov W; Colvin G; Weitzen S
Breast Cancer Res Treat; 2009 Apr; 114(3):569-74. PubMed ID: 18491226
[TBL] [Abstract][Full Text] [Related]
8. Obesity, mammography use and accuracy, and advanced breast cancer risk.
Kerlikowske K; Walker R; Miglioretti DL; Desai A; Ballard-Barbash R; Buist DS
J Natl Cancer Inst; 2008 Dec; 100(23):1724-33. PubMed ID: 19033562
[TBL] [Abstract][Full Text] [Related]
9. Long-term prognostic implications of risk factors associated with tumor size: a case study of women regularly attending screening.
Strand F; Humphreys K; Holm J; Eriksson M; Törnberg S; Hall P; Azavedo E; Czene K
Breast Cancer Res; 2018 Apr; 20(1):31. PubMed ID: 29669579
[TBL] [Abstract][Full Text] [Related]
10. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
11. Obesity as an independent risk factor for decreased survival in node-positive high-risk breast cancer.
Scholz C; Andergassen U; Hepp P; Schindlbeck C; Friedl TW; Harbeck N; Kiechle M; Sommer H; Hauner H; Friese K; Rack B; Janni W
Breast Cancer Res Treat; 2015 Jun; 151(3):569-76. PubMed ID: 25962694
[TBL] [Abstract][Full Text] [Related]
12. Relationship between body mass index and the expression of hormone receptors or human epidermal growth factor receptor 2 with respect to breast cancer survival.
Jeon YW; Kang SH; Park MH; Lim W; Cho SH; Suh YJ
BMC Cancer; 2015 Nov; 15():865. PubMed ID: 26546331
[TBL] [Abstract][Full Text] [Related]
13. Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.
Chuang SL; Chen SL; Yu CP; Chang KJ; Yen AM; Chiu SY; Fann JC; Tabár L; Stephen DW; Smith RA; Chen HH
APMIS; 2014 Aug; 122(8):699-707. PubMed ID: 25046200
[TBL] [Abstract][Full Text] [Related]
14. Being Overweight or Obese Increases the Risk of Progression in Triple-Negative Breast Cancer after Surgical Resection.
Choi Y; Park SK; Ahn KJ; Cho H; Kim TH; Yoon HK; Lee YH
J Korean Med Sci; 2016 Jun; 31(6):886-91. PubMed ID: 27247497
[TBL] [Abstract][Full Text] [Related]
15. Body mass index, diabetes, and triple-negative breast cancer prognosis.
Tait S; Pacheco JM; Gao F; Bumb C; Ellis MJ; Ma CX
Breast Cancer Res Treat; 2014 Jul; 146(1):189-97. PubMed ID: 24869799
[TBL] [Abstract][Full Text] [Related]
16. [Women's cancer screening according to Body Mass Index in a cohort of rural Korean women].
Kim BH; Koh SB; Hur HK; Park JK; Park SM
J Korean Acad Nurs; 2009 Oct; 39(5):641-50. PubMed ID: 19901494
[TBL] [Abstract][Full Text] [Related]
17. Mode of detection: an independent prognostic factor for women with breast cancer.
Hofvind S; Holen Å; Román M; Sebuødegård S; Puig-Vives M; Akslen L
J Med Screen; 2016 Jun; 23(2):89-97. PubMed ID: 26582492
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and behaviour of screen-detected ductal carcinoma in situ of the breast: comparison with symptomatic patients.
Koh VC; Lim JC; Thike AA; Cheok PY; Thu MM; Tan VK; Tan BK; Ong KW; Ho GH; Tan WJ; Tan Y; Salahuddin AS; Busmanis I; Chong AP; Iqbal J; Thilagaratnam S; Wong JS; Tan PH
Breast Cancer Res Treat; 2015 Jul; 152(2):293-304. PubMed ID: 26077641
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for breast cancer in women undergoing mammography.
Reuter KL; Baker SP; Krolikowski FJ
AJR Am J Roentgenol; 1992 Feb; 158(2):273-8. PubMed ID: 1729780
[TBL] [Abstract][Full Text] [Related]
20. Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status--the Japan public health center-based prospective study.
Suzuki R; Iwasaki M; Inoue M; Sasazuki S; Sawada N; Yamaji T; Shimazu T; Tsugane S;
Int J Cancer; 2011 Sep; 129(5):1214-24. PubMed ID: 21064092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
